BR112018012922A2 - fórmula infantil que compreende peptídeos de leite humano - Google Patents

fórmula infantil que compreende peptídeos de leite humano

Info

Publication number
BR112018012922A2
BR112018012922A2 BR112018012922A BR112018012922A BR112018012922A2 BR 112018012922 A2 BR112018012922 A2 BR 112018012922A2 BR 112018012922 A BR112018012922 A BR 112018012922A BR 112018012922 A BR112018012922 A BR 112018012922A BR 112018012922 A2 BR112018012922 A2 BR 112018012922A2
Authority
BR
Brazil
Prior art keywords
infant formula
human milk
milk peptides
peptides
human
Prior art date
Application number
BR112018012922A
Other languages
English (en)
Inventor
John Clarke Andrew
Suchin Trivedi Malav
Original Assignee
A2 Milk Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A2 Milk Co Ltd filed Critical A2 Milk Co Ltd
Publication of BR112018012922A2 publication Critical patent/BR112018012922A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/16Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A23J1/202Casein or caseinates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/54Proteins
    • A23V2250/542Animal Protein
    • A23V2250/5424Dairy protein
    • A23V2250/54246Casein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pediatric Medicine (AREA)

Abstract

trata-se de uma composição de fórmula infantil que contém um ou mais peptídeos beta-casomorfina humanos ou proteínas precursoras dos mesmos.
BR112018012922A 2015-12-22 2016-12-21 fórmula infantil que compreende peptídeos de leite humano BR112018012922A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562270955P 2015-12-22 2015-12-22
PCT/NZ2016/050203 WO2017111618A1 (en) 2015-12-22 2016-12-21 Infant formula comprising human milk peptides

Publications (1)

Publication Number Publication Date
BR112018012922A2 true BR112018012922A2 (pt) 2018-12-11

Family

ID=59090893

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018012922A BR112018012922A2 (pt) 2015-12-22 2016-12-21 fórmula infantil que compreende peptídeos de leite humano

Country Status (16)

Country Link
US (1) US20190000128A1 (pt)
EP (1) EP3393493A4 (pt)
JP (1) JP2018537997A (pt)
KR (1) KR20180096704A (pt)
CN (1) CN108472335A (pt)
AU (1) AU2016377254A1 (pt)
BR (1) BR112018012922A2 (pt)
CA (1) CA3009360A1 (pt)
CL (1) CL2018001728A1 (pt)
IL (1) IL260201A (pt)
MX (1) MX2018007819A (pt)
PH (1) PH12018550097A1 (pt)
RU (1) RU2018123201A (pt)
SG (1) SG11201805264RA (pt)
TW (1) TW201722295A (pt)
WO (1) WO2017111618A1 (pt)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021092669A1 (pt) * 2019-11-12 2021-05-20 Nunes Jose Composto lácteo de água de coco e leite de cabra e uso do composto

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ746167A (en) * 2016-03-30 2023-04-28 A2 Milk Co Ltd Beta-caseins and cognitive function
AU2021301233A1 (en) * 2020-07-01 2023-01-05 Frieslandcampina Nederland B.V. Process for the preparation of a powdery composition comprising bioactive molecules

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020015A (en) * 1988-09-22 2000-02-01 Gaull; Gerald E. Infant formula compositions and nutrition containing genetically engineered human milk proteins
WO1993004171A1 (en) * 1991-08-19 1993-03-04 Symbicom Aktiebolag Human beta-casein, process for producing it and use thereof
JP2003503038A (ja) * 1999-06-29 2003-01-28 ザ・ニュージーランド・ミルク・インスティチュート・リミテッド 乳を主成分とする予防的補助食品
CN103315063A (zh) * 2012-03-19 2013-09-25 基斯有限公司 可预防疾病的婴儿配方奶粉
SG10201801156RA (en) * 2013-08-23 2018-03-28 A2 Milk Co Ltd Beta-casein a2 and blood glucose levels

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021092669A1 (pt) * 2019-11-12 2021-05-20 Nunes Jose Composto lácteo de água de coco e leite de cabra e uso do composto

Also Published As

Publication number Publication date
KR20180096704A (ko) 2018-08-29
TW201722295A (zh) 2017-07-01
JP2018537997A (ja) 2018-12-27
EP3393493A4 (en) 2019-06-26
PH12018550097A1 (en) 2019-02-11
CL2018001728A1 (es) 2018-09-28
CN108472335A (zh) 2018-08-31
SG11201805264RA (en) 2018-07-30
US20190000128A1 (en) 2019-01-03
MX2018007819A (es) 2018-12-17
IL260201A (en) 2018-07-31
EP3393493A1 (en) 2018-10-31
WO2017111618A1 (en) 2017-06-29
AU2016377254A1 (en) 2018-07-12
RU2018123201A3 (pt) 2020-03-02
RU2018123201A (ru) 2020-01-23
CA3009360A1 (en) 2017-06-29

Similar Documents

Publication Publication Date Title
MA50205A (fr) Formulation de nicotine
EA201891083A1 (ru) Составы антител к cd38 для подкожного введения и их применение
EA201890052A1 (ru) Регуляторы nrf2
EA201692316A1 (ru) Производные холана для применения при лечении и/или профилактике fxr и tgr5/gpbar1-опосредованных заболеваний
EA201691582A1 (ru) Новые фармацевтические препараты
DK3244948T3 (da) Bestemmelse af medikamentdosis
BR112016028891A2 (pt) processos de trens de sementes e usos dos mesmos
EA201690372A1 (ru) Азапиридоновые соединения и их применение
MA46180A (fr) Analogues de l'amyline
EA201691259A1 (ru) РЕГУЛЯТОРЫ Nrf2
EA201592143A1 (ru) Новые бициклические ингибиторы бромодомена
EA201890858A1 (ru) 2,4-дигидроксиникотинамиды как агонисты apj
EA201591728A1 (ru) Гетероциклические соединения и способы их применения
DK3785733T3 (da) Farmaceutisk sammensætning til behandling af autisme
DK3498278T3 (da) Forbindelser til behandling af sygdomme relateret til DUX4-ekspression
EA201591931A1 (ru) Композиции оксабициклогептанов и оксабициклогептенов
EA201690371A1 (ru) Пиридазиноновые соединения и их применение
EA201790650A1 (ru) Лекарственная форма и способы применения абиратерона ацетата
MA43987A (fr) Détermination de la pureté de protéine multimère
EA201790570A1 (ru) Модуляторы р2х7
DK3166628T3 (da) Terapeutisk anvendelse af knoglemorfogenetiske proteiner
EP3199554A4 (en) Antibody capable of neutralizing substance having activity alternative to function of coagulation factor viii (fviii)
EA201791992A1 (ru) Ингибиторы грелин-o-ацилтрансферазы
DK3793960T3 (da) Kalkmælk
DK3551181T3 (da) Behandling omfattende oral eller gastrisk indgivelse af edaravone

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]